Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

Clinical trial NCT01205724 · COMPLETED

Trial details

NCT number: NCT01205724
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2010-09-01
Primary completion: 2011-04-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.